Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Michele Malagola, Nicola Polverelli, Massimo Martino, Vicky Rubini, Maria Teresa Lupo Stanghellini, Francesca Patriarca, Renato Fanin, Benedetto Bruno, Luisa Giaccone, Danilo Giuseppe Faraci, Giovanni Grillo, Stefania Bramanti, Luca Castagna, Paolo Bernasconi, Anna Amelia Colombo, Marco De Gobbi, Paolo Nicoli, Annalisa Natale, Stella Santarone, Elisabetta Terruzzi, Attilio Olivieri, Ilaria Scortechini, Patrizia Chiusolo, Elisabetta Metafuni, Angelo Michele Carella, Emanuela Merla, Marco Casini, Irene M Cavattoni, Mario Arpinati, Chiara Nozzoli, Ilaria Cutini, Patrizio Mazza, Annamaria Mazzone, Simona Bassi, Francesco Onida, Giorgia Saporiti, Filippo Antonio Canale, Adriana Vacca, Eugenia Piras, Piero Galieni, Sadia Falcioni, Mario Luppi, Giulia Debbia, Anna Paola Iori, Ursula La Rocca, Vincenzo Pavone, Anna Mele, Cristina Skert, Francesca Carobolante, Paola Carluccio, Carlo Borghero, Francesca Elice, Anna Proia, Fulvia Fanelli, Carmine Selleri, Nicoletta Sacchi, Sonia Mammoliti, Elena Oldani, Fabio Ciceri, Francesca Bonifazi, Domenico Russo

Blood (2021) 138 (Supplement 1): 1786.

https://doi.org/10.1182/blood-2021-145970

Published: 2021

Journal Articles

Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association

Blood (2021) 138 (Supplement 1): 3887.

https://doi.org/10.1182/blood-2021-150013

Published: 2021

Journal Articles

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

Blood (2018) 132 (24): 2594–2607.

https://doi.org/10.1182/blood-2018-07-861575

Published: 2018

Includes: Supplemental data

Journal Articles

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

Francesca Lorentino, Nicoletta Sacchi, PhD BSc, Elena Oldani, MSc, Valeria Miotti, Alessandra Picardi, Anna Maria Gallina, Paolo Bernasconi, Riccardo Saccardi, MD, Lucia Farina, MD, Fabio Benedetti, Francesca Patriarca, MD, Michela Cerno, Benedetto Bruno, Alessandro Rambaldi, MD, Fabio Ciceri, MD, Katharina Fleischhauer, Luca Vago, MD PhD, Francesca Bonifazi

Blood (2018) 132 (Supplement 1): 482.

https://doi.org/10.1182/blood-2018-99-115216

Published: 2018

Journal Articles

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Blood (2018) 132 (Supplement 1): 4642.

https://doi.org/10.1182/blood-2018-99-114486

Published: 2018

Journal Articles

Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network

Blood (2017) 130 (Supplement 1): 4554.

https://doi.org/10.1182/blood.V130.Suppl_1.4554.4554

Published: 2017

Journal Articles

In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Blood (2012) 120 (21): 221.

https://doi.org/10.1182/blood.V120.21.221.221

Published: 2012

Journal Articles

Definitions of histocompatibility typing terms

Eduardo Nunes, Helen Heslop, Marcelo Fernandez-Vina, Cynthia Taves, Dawn R. Wagenknecht, A. Bradley Eisenbrey, Gottfried Fischer, Kay Poulton, Kara Wacker, Carolyn Katovich Hurley, Harriet Noreen, Nicoletta Sacchi

Blood (2011) 118 (23): e180–e183.

https://doi.org/10.1182/blood-2011-05-353490

Published: 2011

Journal Articles

Quality of Cord-Blood Units and Hematological Recovery After Intra Bone CBT Are Not Influenced by the Bank of Origin and by the Time of Cryopreservation

Naoki Kurita, MD, Francesco Frassoni, MD, Nicoletta Sacchi, PhD, BSc, Claudia Cossu, Biol Sci, Alberto Serio, Tech., Daniela Cilloni, MD, PhD, Marina Podestà, PhD

Blood (2011) 118 (21): 4400.

https://doi.org/10.1182/blood.V118.21.4400.4400

Published: 2011

Journal Articles

The Intra-Bone Route of Administration of Cord blood cells extends the Possibility of Transplantation to the Majority of Patients with Malignant Hematopoietic Diseases.

Francesco Frassoni, MD, Marina Podestà, BiolSci, Simona Pollichieni, Ph.D., Francesca Gualandi, MD, GianLuca Ubezio, MD, Lucia Garbarino, MD, Teresa Lamparelli, MD, Riccardo Varaldo, MD, Gianmario Sambuceti, MD, Myriam Labopin, MD, Andrea Bacigalupo, MD, Nicoletta Sacchi, Ph.D

Blood (2009) 114 (22): 3376.

https://doi.org/10.1182/blood.V114.22.3376.3376

Published: 2009

Journal Articles

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Roberto Crocchiolo, Elisabetta Zino, Luca Vago, Rosi Oneto, Barbara Bruno, Simona Pollichieni, Nicoletta Sacchi, Maria Pia Sormani, Jessica Marcon, Teresa Lamparelli, Renato Fanin, Lucia Garbarino, Valeria Miotti, Giuseppe Bandini, Alberto Bosi, Fabio Ciceri, Andrea Bacigalupo, Katharina Fleischhauer, for the Gruppo Italiano Trapianto di Midollo Osseo, Cellule Staminale Ematopoietiche (CSE) e Terapia Cellulare, and the Italian Bone Marrow Donor Registry

Blood (2009) 114 (7): 1437–1444.

https://doi.org/10.1182/blood-2009-01-200378

Published: 2009

Journal Articles

NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation

Roberto Crocchiolo, M.D., Elisabetta Zino, M.D., Nicoletta Sacchi, Ph.D., Jessica Marcon, M.D., Simona Pollichieni, Ph.D., Rosi Oneto, Ph.D., Giuseppe Bandini, M.D., Andrea Bacigalupo, MD, Fabio Ciceri, M.D., Katharina Fleischhauer, M.D.

Blood (2008) 112 (11): 562.

https://doi.org/10.1182/blood.V112.11.562.562

Published: 2008

Journal Articles

Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study.

Roberto Crocchiolo, MD, Fabio Ciceri, MD, Rosa Oneto, MD, Barbara Bruno, MD, Simona Pollichieni, MD, Nicoletta Sacchi, MD, Maria Pia Sormani, MD, Renato Fanin, MD, Giuseppe Bandini, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Paolo Emilio Alessandrino, MD, Michele Falda, MD, Andrea Bacigalupo, MD

Blood (2007) 110 (11): 3052.

https://doi.org/10.1182/blood.V110.11.3052.3052

Published: 2007

Journal Articles

A Randomized Trial of Rabbit Anti-Thymocyte Globulin, Given on Day+7 after Alternative Donor Transplants.

Andrea Bacigalupo, Teresa Lamparelli, Fabio Ciceri, Fedro Peccatori, Anna Locasciulli, Ignazio Majolino, Paolo Di Bartolomeo, Giuseppe Milone, Patrizio Mazza, Pasquale Lacopino, Nicoletta Sacchi, Maria Teresa van Lint

Blood (2006) 108 (11): 754.

https://doi.org/10.1182/blood.V108.11.754.754

Published: 2006

Journal Articles

Unrelated Hematopoietic Stem Cell Transplantation with Reduced Intensity Regimens in High Risk Patients for Age or Disease: Results from Two Independent Prospective GITMO Studies.

Alberto Bosi, Andrea Bacigalupo, Davide Soligo, Renato Fanin, Teresa Lamparelli, Fabio Benedetti, Letizia Lombardini, Nicoletta Sacchi, Simona Pollicheni, Alessandro Rambaldi

Blood (2005) 106 (11): 2888.

https://doi.org/10.1182/blood.V106.11.2888.2888

Published: 2005

Journal Articles

Long Term Follow up of Two Randomized Trials on Antithymocyte Globulin (ATG) for GVHD Prophylaxis in Unrelated Donor Transplants: Chronic GVHD, Bronchiolitis and Quality of Life.

Andrea Bacigalupo, MD, Maurizio Vignola, MD, Teresa Lamparelli, MD, Paolo Bruzzi, MD, Stefano Guidi, MD, Paolo Alessandrino, MD, Palo Di Bartolomeo, MD, Rosa Oneto, BS, Barbara Bruno, BS, Mario Barbanti, MD, Nicoletta Sacchi, BS, Maria Teresa Van Lint, MD, Alberto Bosi, MD

Blood (2004) 104 (11): 438.

https://doi.org/10.1182/blood.V104.11.438.438

Published: 2004

Journal Articles

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Andrea Bacigalupo, Teresa Lamparelli, Paolo Bruzzi, Stefano Guidi, Paolo Emilio Alessandrino, Paolo di Bartolomeo, Rosa Oneto, Barbara Bruno, Mario Barbanti, Nicoletta Sacchi, Maria Teresa Van Lint, Alberto Bosi, for Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Blood (2001) 98 (10): 2942–2947.

https://doi.org/10.1182/blood.V98.10.2942

Published: 2001

NARROW

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt

Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network

In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Definitions of histocompatibility typing terms

Quality of Cord-Blood Units and Hematological Recovery After Intra Bone CBT Are Not Influenced by the Bank of Origin and by the Time of Cryopreservation

The Intra-Bone Route of Administration of Cord blood cells extends the Possibility of Transplantation to the Majority of Patients with Malignant Hematopoietic Diseases.

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation

Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study.

A Randomized Trial of Rabbit Anti-Thymocyte Globulin, Given on Day+7 after Alternative Donor Transplants.

Unrelated Hematopoietic Stem Cell Transplantation with Reduced Intensity Regimens in High Risk Patients for Age or Disease: Results from Two Independent Prospective GITMO Studies.

Long Term Follow up of Two Randomized Trials on Antithymocyte Globulin (ATG) for GVHD Prophylaxis in Unrelated Donor Transplants: Chronic GVHD, Bronchiolitis and Quality of Life.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only